The 34th annual meeting of the korean society of gynecologic oncology 2019: Meeting report

Ga Won Yim, Dong Hoon Suh, Jae Weon Kim, Seung Cheol Kim, Young Tae Kim

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


The 34th Annual Meeting of Korean Society of Gynecologic Oncology (KSGO) was held in Busan, Korea from 26 to 27 April. Around 460 Korean and international clinicians gathered in Busan to share and discuss their latest work and key issues of gynecologic oncologic research and treatment. The scope of this meeting included recent clinical trials and updates in gynecologic oncology, advances in ovarian cancer treatment, targeted therapy and immunotherapy in gynecologic cancer, management of hereditary gynecologic cancer, and newly revised staging of cervical cancer. As expected, the ongoing debate regarding the recent clinical trial on minimally invasive surgery for early-stage cervical cancer was addressed throughout the congress and the initial outline of the KSGO position statement was open for discussion. The meeting was an opportunity for all participants to come together and explore scientific insights of gynecologic cancer.

Original languageEnglish
Article numbere91
JournalJournal of Gynecologic Oncology
Issue number4
StatePublished - Jul 2019

Bibliographical note

Publisher Copyright:
© 2019. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology.


  • Endometrial Neoplasms
  • Immunotherapy
  • Molecular Targeted Therapy
  • Ovarian Neoplasms
  • Uterine Cervical Neoplasms


Dive into the research topics of 'The 34th annual meeting of the korean society of gynecologic oncology 2019: Meeting report'. Together they form a unique fingerprint.

Cite this